(Q40678334)

22 September 2017

c-myc is a downstream target of the Smad pathway (English)

1 reference

22 September 2017

Ken Yagi

1

1 reference

22 September 2017

Masao Furuhashi

2

1 reference

22 September 2017

Hiromasa Aoki

3

1 reference

22 September 2017

Daisuke Goto

4

1 reference

22 September 2017

Hiroyuki Kuwano

5

1 reference

22 September 2017

Kazuo Sugamura

6

1 reference

22 September 2017

Kohei Miyazono

7

1 reference

22 September 2017

Mitsuyasu Kato

8

1 reference

22 September 2017

language of work or name

English

0 references

publication date

31 October 2001

1 reference

Journal of Biological Chemistry

22 September 2017

1 reference

22 September 2017

277

1 reference

22 September 2017

854-861

1 reference

22 September 2017

1

1 reference

Transcriptional control by the TGF-beta/Smad signaling system

22 September 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104170200

Signaling inputs converge on nuclear effectors in TGF-beta signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104170200

TGF-beta signaling by Smad proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104170200

TGF-beta signalling from cell membrane to nucleus through SMAD proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104170200

TGFbeta signaling in growth control, cancer, and heritable disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104170200

Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104170200

DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104170200

MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104170200

Mad-related genes in the human

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104170200

Selective inhibition of growth-related gene expression in murine keratinocytes by transforming growth factor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104170200

Suppression of the EGF-dependent induction of c-myc proto-oncogene expression by transforming growth factor beta in a human breast carcinoma cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104170200

Overexpression of the c-Myc oncoprotein blocks the growth-inhibitory response but is required for the mitogenic effects of transforming growth factor beta 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104170200

A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor beta -induced cell-cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104170200

p53-independent role of MDM2 in TGF-beta1 resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104170200

Correlation between suppression of c-myc and antiproliferative effect of transforming growth factor-beta 1 in thyroid carcinoma cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104170200

Effects of transforming growth factor beta-1 on growth-regulatory genes in tumour-derived human oral keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104170200

Growth inhibition by TGF-beta linked to suppression of retinoblastoma protein phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104170200

TGF-beta 1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104170200

Expression of the E2F1 transcription factor overcomes type beta transforming growth factor-mediated growth suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104170200

Early gene responses to transforming growth factor-beta in cells lacking growth-suppressive RB function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104170200

Myc downregulation by transforming growth factor beta required for activation of the p15(Ink4b) G(1) arrest pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104170200

c-Myc regulates cyclin D-Cdk4 and -Cdk6 activity but affects cell cycle progression at multiple independent points

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104170200

A single missense mutant of Smad3 inhibits activation of both Smad2 and Smad3, and has a dominant negative effect on TGF-beta signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104170200

STAM, signal transducing adaptor molecule, is associated with Janus kinases and involved in signaling for cell growth and c-myc induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104170200

Role of p300, a transcriptional coactivator, in signalling of TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104170200

Alternatively spliced variant of Smad2 lacking exon 3. Comparison with wild-type Smad2 and Smad3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104170200

Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104170200

E1A-dependent trans-activation of the human MYC promoter is mediated by the E2F factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104170200

Identification of c-MYC as a target of the APC pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104170200

Activation of c-myc gene expression by tumor-derived p53 mutants requires a discrete C-terminal domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104170200

Ras enhances Myc protein stability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104170200

21 January 2018

Myc activates telomerase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104170200

Cell cycle regulation of E2F site occupation in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104170200

Cell cycle-regulated repression of B-myb transcription: cooperation of an E2F site with a contiguous corepressor element.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104170200

The HIP1 binding site is required for growth regulation of the dihydrofolate reductase gene promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104170200

Multiple DNA elements are required for the growth regulation of the mouse E2F1 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104170200

Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104170200

E2F and histone deacetylase mediate transforming growth factor beta repression of cdc25A during keratinocyte cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104170200

TGF-beta 1 inhibition of transin/stromelysin gene expression is mediated through a Fos binding sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104170200

Identification of a transforming growth factor-beta1/bone morphogenetic protein 4 (TGF-beta1/BMP4) response element within the mouse tissue transglutaminase gene promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104170200

v-Abl activates c-myc transcription through the E2F site

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104170200

A cellular repressor of E1A-stimulated genes that inhibits activation by E2F

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104170200

The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104170200

The essential cofactor TRRAP recruits the histone acetyltransferase hGCN5 to c-Myc

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104170200

Defective repression of c-myc in breast cancer cells: A loss at the core of the transforming growth factor beta growth arrest program

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104170200

21 January 2018

Identifiers

DOI

10.1074/JBC.M104170200

1 reference

22 September 2017

1 reference